Antagonistic properties of centrally truncated analogs of [D-Trp32]NPY

Journal of Medicinal Chemistry

Volumn 39, Issue 5, 1996, Pages 1142-1147

  Balasubramaniam, A ^a   Ujhelyi, M ^b   Borchers, M ^a   Huang, Y ^a   Zhai, W ^a   Zhou, Y ^c   Johnson, M ^c   Sheriff, S ^a   Fischer, J E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; DOSE RESPONSE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; HEMODYNAMICS; HUMAN; HUMAN CELL; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; TUMOR CELLS, CULTURED;

EID: 0029877279     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9505371     Document Type: Article

References (39)

1. Tatemoto, K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl. Acad. Sci. U.S.A. 1982, 79, 5485-5489.
2. Glover, D. D.; Barlow, D. J.; Pitts, J. E.; Wood, S. P.; Tickle, I. J.; Blundell, T L.; Tatemoto, K.; Kimmel, J. R.; Wollmer, A., Strassburger, W.; Zhang, Y. S. Conformational studies on the pancreatic polypeptide hormone family. Eur. J. Biochem. 1985, 142, 379-385.
3. Balasubramaniam, A.; Huang, S.-G.; Sherriff, S.; Prabhakaran, M ; Renugopalakrishnan, V. Proteins, Structure, Dynamics and Design; Renugopalakrishnan, V., Carey, P R., Smith, I. C. P., Huang, S. G., Storer, A. C., Eds.; Escom Science Publishers: Leiden, The Netherlands, 1990; pp 79-81.
4. 1H NMR assignment and secondary structure of neuropeptide Y in aqueous solution. Biochemistry 1990, 29, 4509-4515.
5. Wahlestedt, C.; Reis D. J. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 1993, 32, 309-352.
6. Michel, M. C Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 1991, 12, 389-394.
7. Balasubramaniam, A.; Sheriff, S.; Rigel, D. F.; Fischer, J. E. Characterization of neuropeptide Y receptors in rat cardiac ventricular memberanes. Peptides 1990, 11, 545-550.
8. Wahlestedt, C.; Grundemar, L.; Hakanson, R.; Heilig, M.; Shen, G. H. Zukowska-Grojec, Z.; Reiss, D. J. Neuropeptide Y receptor subtypes, Y1 and Y2. Ann. N. Y Acad. Sci. 1990, 611, 7-26.
9. Sheriff, A.; Balasubramaniam, A. Inhibitory and stimulatory effects of neuropeptide Y (17-36): structure-function studies. J. Biol. Chem. 1992, 267, 4690-4685.
10. Balasubramaniam, A.; Sheriff, S. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventribular membranes. J Biol. Chem. 1990, 285, 14724-14727.
11. Balasubramaniam, A.; Sheriff, S.; Johnson, M. E.; Prabhakaran, M.; Huang, Y.; Fischer J. E.; Chance, W. T [D-Trp32]NPY is a competive antagonist of NPY in rat hypotalamus. J. Med. Chem. 1994, 37, 811-815.
12. Tatemoto, K. Neuropeptide Y and its receptor and antagonists: use of an analog mixture strategy. Ann. N. Y. Acad. Sci. 1990, 611, 106-109.
13. 1-type receptor. J. Med. Chem. 1995, 38, 1150-1157.
14. Chaurasia, C.; Misse, G.; Tessel, R.; Doughty, M. B. Nonapeptidepeptidomimetic antagonists of neuropeptide Y receptor benextramine analogs with selectivity for the peripheral receptor. J. Med. Chem 1994, 37, 2242-2248.
15. Edvinsson, L.; Adamsson, M.; Jansen, I. Neuropeptide Y antagonistic properties of D-myo-inositol-1,2,6-trisphosphate in guinea pig basilar arteries. Neuropeptides 1990, 17, 99-105.
16. Rudolf, K.; Eberlein, W.; Engel, E.; Wieland, H. A.; William, K. D.; Entzeroth, M.; Wienen, W.; Beck-Sickinger, A. G.; Doods, H. N. The first potent and selective non-peptide neuropeptide Y Y1 antagonist: BIBP3226. Eur. J. Pharmacol. 1994, 271, R11-R13.
17. Serradeil-Le Gal, C.; Valette, G.; Rouby, P. E.; Pellet, A; Oury-Donat, F.; Brassard, G.; Lespy, L.; Marty, E.; Neliat, G.; De Cointet, P.; Maffrand, J P.; Le Fur, G. An orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett. 1995, 362, 192-196.
18. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Millar, B. C., Weis, T.; Piper, H. M.; Weber, M.; Borchard, U.; McDermott, B. J.; Balasubramaniam, A. Am. J. Physiol. 1991, 261, H1727-H1733.
19. 3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. J. Pharmacol. Exp. Therap. 1992, 262, 1212-1218.
20. Chang, F.; Yu, H.; Cohen, I. S. Actions of vasoactive intestinal peptide and neuropeptide Y on the pacemaker current in canine Purkinje fibers. Circ. Res. 1994, 74, 157-162.
21. 1 receptors on SK-N-MC cells. Neurosci. Lett. 1990, 119, 187-190.
22. McLaughlin, C. L; Tou, J. S.; Rogan, G. J.; Baile, C. A. Fullamino acid sequence of centrally administered NPY required for maximal food intake response. Physiol. Behav. 1991, 49, 521-526.
23. 125I-labeled peptide YY binding sites in the rat brain. Neurochem. Int. 1992, 21, 45-67.
24. Krstenanstky, J. L.; Owen, T. J.; Buck, S. H.; Hagaman, K. A.; Mc Lean, L. R. Centrally truncated and stabilized porcine neuropeptide Y analogues design, synthesis, and mouse brain receptor binding. Proc. Natl. Acad. Sci. U.S.A. 1980, 86, 4377-4381.
25. Beck, A.; Jung, G.; Gaida, W.; Koppen, H.; Lang, R.; Schnorrenberg, G. Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via a spacer to α-helical NPY 25-36. FEBS Lett. 1989, 1, 119-122.
26. Kirby, D. A.; Koerber, S. C.; Craig, A. G.; Feinstein R. D.; Delmas, L.; Brown, M. R.; Rivier, J. E. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues. J. Med. Chem. 1993, 36, 385-393.
27. Balasubramaniam, A.; Knittel, J. J.; Gil, C.; Andrews, P. C. Detection of conformational isomers of anglerfish peptide YG (aPY) by reversed phase chromotography. Int. J. Pept. Protein Res. 1989, 34, 158-160.
28. Michel, M. C.; Gaida, W.; Beck-Sickinger, A. G.; Wieland, H. A.; Doods, Dürr, H.; Jung, G.; Schnorrenberg, G. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol. Pharmacol. 1992, 42, 642-648.
29. Freidinger, R. M.; Perlow, D. S.; Randall, W. C.; Saperstein, R.; Arison, B. H.; Veber, D. F. Conformational modifications of cyclic hexapeptide somatostatin analogs. Int. J. Pept. Protein Res. 1984, 12, 142-150.
30. Schmidt, R.; Kalman, A.; Chung, N. N.; Lemieux, C.; Horvath, C.; Schiller, P. W. Structure-activity relationship of dermorphin analogues containing N-substituted aminon acids in the 2-position of peptide sequence. Int. J. Pept. Protein Res. 1995, 46, 47-55.
31. Freidinger, R. M.; Cotton, C. D.; Randal, W. C.; Pitzenberger, S. M.; Veber, D. F. A cyclic hexapeptide LH-RH antagonist. Peptides: Structure and Function; Deber, C. M., Hruby, V. J., Kopple, K. D., Eds.; Pierce Chemical Co.: Rockford, IL, 1990; pp 549-552.
32. 2. Endocrinology 1988, 123, 2597-2599
33. Shigeri, Y.; Fujimoto, M. Two different signal transductions of neuropeptide Y1 receptor in SK-N-MC cells. Biochem. Biophys. Res. Commun. 1992, 187, 1565-1571.
34. Balasubramaniam, A.; Grupp, L.; Srivastava, L.; Tatemoto, K.; Murphy, R. F.; Joffe, S. N.; Fischer, J. E. Synthesis of Neuropeptide Y Int. J. Pept. Protein Res. 1987, 29, 78-83.
35. Felix, A. M.; Wang, C.-T.; Heimer, E. P.; Fournier, A. Applications of BOP reagent in solid phase synthesis. Int. J. Pept. Protein Res. 1988, 31, 231-238.
36. Balasubramaniam, J. E.; Sheriff, S.; Rigel, D. F.; Fischer, J. E. Characterization of neuropeptide Y receptor in rat ventricular membranes. Peptides 1990, 11, 545-550.
37. Daniels, A. J.; Matthews, J. E.; Viveros, O. H.; Lazarowski, E. R. Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells. Mol. Pharmacol. 1992, 41, 767-771.
38. Feth, F.; Rascher, W.; Michel, M. C. Neuropeptide Y (NPY) receptors in HEL cells: comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist. Br. J. Pharmacol. 1992, 105, 71-76.
39. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260, 3440-3450.